Lokalisationsdiagnostik von Nebenschilddrüsenadenomen mittels PET/CT

Andreas Odparlik; Andreas Hendrik Hering

doi:10.1055/a-1128-8903

Der Nuklearmediziner, Table of Contents

Der Nuklearmediziner 2020; 43(03): 244-248
DOI: 10.1055/a-1128-8903

Schilddrüse und Nebenschilddrüse

Lokalisationsdiagnostik von Nebenschilddrüsenadenomen mittels PET/CT

Localisation imaging of parathyroid adenomas using PET-CT

Authors

Andreas Odparlik

Department für Strahlenmedizin, Abteilung Nuklearmedizin, Universitätsklinikum Halle (Saale)
Andreas Hendrik Hering

Department für Strahlenmedizin, Abteilung Nuklearmedizin, Universitätsklinikum Halle (Saale)

Abstract

Zusammenfassung

Die häufigste Ursache eines primären Hyperparathyreoidismus ist ein funktionell relevantes Nebenschilddrüsenadenom, welches meist solitär, teils jedoch auch ektop vorkommen kann. In Vorbereitung der kausalen Therapie, dem operativen Vorgehen, ist eine exakte Lokalisationsdiagnostik essenziell um den Eingriff genau zu planen und so wenig traumatisch wie möglich zu gestalten. Dadurch kann die Häufigkeit von Komplikationen wie postoperativem Hypoparathyreoidismus, aber z. B. auch einer Recurrensparese deutlich vermindert werden. In der Regeldiagnostik kommen zervikaler Ultraschall, MRT und ^99 mTc-MIBI-Szintigrafie zur Anwendung. Bei fehlendem oder uneindeutigem Befund kann eine ergänzende PET-Diagnostik (¹⁸F-Cholin; ¹¹C-Cholin; ¹¹C-Methionin) erfolgen, wodurch häufig doch noch eine Lokalisierung gelingt. Im Vergleich zum Einsatz von Subtraktionsszintigrafie und SPECT/CT wird für den Einsatz der PET/CT zudem eine niedrigere Strahlenexposition für die Patienten beschrieben.

Abstract

Parathyroid adenomas are the most common cause of primary hyperparathyroidism. Proper pretreatment localisation is essential to plan the surgical approach with a minimum of risk (e. g. hypoparathyroidism or recurrent nerve paralysis). Cervical ultrasound, MRI and ^99mTc-MIBI-scintigraphy are used routinely. In case of a lack of diagnostic findings the use PET-CT (¹⁸F-choline; ¹¹C-choline; ¹¹C-methionine) is reasonably. Detection of parathyroid adenoma is able in many cases causing less radiation exposure than conventional imaging.

Schlüsselwörter

Primärer Hyperparathyreoidismus - Nebenschilddrüsenadenom - ^99 mTc-MIBI-Szintigrafie - ¹⁸F-Cholin - ¹¹C-Cholin - ¹¹C-Methionin PET/CT

Keywords

Primary hyperparathyroidism - parathyroid adenoma - 99m-Tc-MIBI-scintigraphy - F-18-choline - C-11-choline - C11-methionine PET-CT

Full Text

References

Literatur
1 Bilezikian JP. Primary Hyperparathyroidism. J Clin Endocrinol Metab 2018; 103: 3993-4004
2 Heath H, Sizemore GW, Carney JA. Preoperative diagnosis of occult parathyroid hyperplasia by calcium infusion in patients with multiple endocrine neoplasia, type 2a. J Clin Endocrinol Metab 1976; 43: 428-435
3 Miedlich S, Koch CA, Paschke R. Primärer Hyperparathyreoidismus: Heute ein meist asymptomatisches Krankheitsbild. Dtsch Arztebl Int 2002; 99: A-3340
4 Taieb D, Hindie E, Grassetto G. et al. Parathyroid Scintigraphy: When, How, and Why? A Concise Systematic Review. Clin Nucl Med 2012; 37: 568-574
5 Wilhelm SM, Wang TS, Ruan DT. et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg 2016; 151: 959
6 Urkan M, Peker YS, Ozturk E. MINIMALLY INVASIVE PARATHYROIDECTOMY FOR PRIMARY HYPERPARATHYROIDISM. Acta Endocrinol Buchar Rom 2005 2019; 15: 182-186
7 Udelsman R, Lin Z, Donovan P. The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg 2011; 253: 585-591
8 Mak NTJJ, Li J, Vasilyeva E. et al. Intraoperative parathyroid hormone measurement during parathyroidectomy for treatment of primary hyperparathyroidism: When should you end the operation?. Am J Surg 2020; 219: 785-789
9 Azizi G, Mayo ML, Keller J. et al. Diagnosis of Parathyroid Adenomas with New Ultrasound Imaging Modalities. VideoEndocrinology 2019; 6: ve.2019.0163
10 Kuzminski SJ, Sosa JA, Hoang JK. Update in Parathyroid Imaging. Magn Reson Imaging Clin N Am 2018; 26: 151-166
11 Ozturk M, Polat AV, Celenk C. et al. The diagnostic value of 4D MRI at 3T for the localization of parathyroid adenomas. Eur J Radiol 2019; 112: 207-213
12 Memeh KO, Palacios JE, Khan R. et al. PRE-OPERATIVE LOCALIZATION OF PARATHYROID ADENOMA: PERFORMANCE OF 4D MRI PARATHYROID PROTOCOL. Endocr Pract 2019; 25: 361-365
13 Amadou C, Bera G, Ezziane M. et al. 18F Fluorocholine PET/CT and Parathyroid 4D Computed Tomography for Primary Hyperparathyroidism: The Challenge of Reoperative Patients. World J Surg 2019; 43: 1232-1242
14 Beheshti M, Hehenwarter L, Paymani Z. et al. 18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients. Eur J Nucl Med Mol Imaging 2018; 45: 1762-1771
15 Morland D, Lalire P, Deguelte S. et al. Added value of 18F-fluorocholine positron emission tomography-computed tomography in presurgical localization of hyperfunctioning parathyroid glands after dual tracer subtraction scintigraphy failure: A retrospective study of 47 patients. Medicine (Baltimore) 2020; 99: e18681
16 Michaud L, Balogova S, Burgess A. et al. A Pilot Comparison of 18F-fluorocholine PET/CT, Ultrasonography and 123I/99mTc-sestaMIBI Dual-Phase Dual-Isotope Scintigraphy in the Preoperative Localization of Hyperfunctioning Parathyroid Glands in Primary or Secondary Hyperparathyroidism: Influence of Thyroid Anomalies. Medicine (Baltimore) 2015; 94: e1701
17 Liu Y, Dang Y, Huo L. et al. Preoperative localisation of adenomas in primary hyperparathyroidism: the value of 11 C-choline PET/CT in patients with negative or discordant ultrasonography and 99m Tc-Sesta-MIBI-SPECT/CT. J Nucl Med 2020; 61: 584-589
18 Kluijfhout WP, Pasternak JD, Drake FT. et al. Use of PET tracers for parathyroid localization: a systematic review and meta-analysis. Langenbecks Arch Surg 2016; 401: 925-935
19 Parikh AM, Grogan RH, Morón FE. Localization of Parathyroid Disease in Reoperative Patients with Primary Hyperparathyroidism. Int J Endocrinol 2020; 2020: 1-15
20 Krakauer M, Kjaer A, Bennedbæk FN. (18)F-FET-PET in Primary Hyperparathyroidism: A Pilot Study. Diagn Basel Switz 2016; 6: 30
21 Treglia G, Piccardo A, Imperiale A. et al. Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 2019; 46: 751-765
22 Broos WAM, van der Zant FM, Knol RJJ. et al. Choline PET/CT in parathyroid imaging: a systematic review. Nucl Med Commun 2019; 40: 96-105
23 Kluijfhout WP, Pasternak JD, Gosnell JE. et al. 18F Fluorocholine PET/MR Imaging in Patients with Primary Hyperparathyroidism and Inconclusive Conventional Imaging: A Prospective Pilot Study. Radiology 2017; 284: 460-467
24 Alharbi AA, Alshehri FM, Albatly AA. et al. [18F]Fluorocholine Uptake of Parathyroid Adenoma Is Correlated with Parathyroid Hormone Level. Mol Imaging Biol 2018; 20: 857-867
25 Piccardo A, Trimboli P, Rutigliani M. et al. Additional value of integrated 18F-choline PET/4D contrast-enhanced CT in the localization of hyperfunctioning parathyroid glands and correlation with molecular profile. Eur J Nucl Med Mol Imaging 2019; 46: 766-775
26 Boccalatte LA, Gómez NL, Olivera López S. et al. Ectopic hyperparathyroidism Detection of mediastinal localization. Medicina (Mex) 2020; 80: 39-47
27 Rep S, Hocevar M, Vaupotic J. et al. 18 F-choline PET/CT for parathyroid scintigraphy: significantly lower radiation exposure of patients in comparison to conventional nuclear medicine imaging approaches. J Radiol Prot 2018; 38: 343-356
28 Cuderman A, Senica K, Rep S. et al. 18F-Fluorocholine PET/CT in primary hyperparathyroidism: superior diagnostic performance to conventional scintigraphic imaging for localization of hyperfunctioning parathyroid glands. J Nucl Med Off Publ Soc Nucl Med 2019; 61: 577-583
29 ZajíčKová K, Zogala D, Kubinyi J. Parathyroid Imaging by 18F-Fluorocholine PET/CT in Patients With Primary Hyperparathyroidism and Inconclusive Conventional Methods: Clinico-Pathological Correlations. Physiol Res 2018; 67 (Suppl. 03) S551-S557
30 Kluijfhout WP, Vorselaars WMCM, van den Berk SAM. et al. Fluorine-18 fluorocholine PET-CT localizes hyperparathyroidism in patients with inconclusive conventional imaging: a multicenter study from the Netherlands. Nucl Med Commun 2016; 37: 1246-1252
31 Fischli S, Suter-Widmer I, Nguyen BT. et al. The Significance of 18F-Fluorocholine-PET/CT as Localizing Imaging Technique in Patients with Primary Hyperparathyroidism and Negative Conventional Imaging. Front Endocrinol 2018; 8 Im Internet: http://journal.frontiersin.org/article/10.3389/fendo.2017.00380/full
32 Grimaldi S, Young J, Kamenicky P. et al. Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of 18F-Fluorocholine PET/CT. Eur J Nucl Med Mol Imaging 2018; 45: 1772-1780
33 Huber GF, Hüllner M, Schmid C. et al. Benefit of 18F-fluorocholine PET imaging in parathyroid surgery. Eur Radiol 2018; 28: 2700-2707
34 Boccalatte LA, Higuera F, Gómez NL. et al. Usefulness of 18 F-Fluorocholine Positron Emission Tomography–Computed Tomography in Locating Lesions in Hyperparathyroidism: A Systematic Review. JAMA Otolaryngol Neck Surg 2019; 145: 743